Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells
- PMID: 17214970
- DOI: 10.1016/j.bbrc.2006.12.181
Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells
Abstract
Matrix metalloproteinase-9 (MMP-9) plays an important role in the invasion and metastasis of cancer cells. In this study, we examined the inhibitory effect of silibinin, a flavonoid antioxidant from milk thistle (Silybum marianum L.) on PMA-induced MMP-9 expression in MCF-7 human breast carcinoma cells. Silibinin significantly and selectively suppressed PMA-induced MMP-9 expression in MCF-7. Silibinin has been found to inhibit PMA-induced MMP-9 gene transcriptional activity by blocking the activation of AP-1 via MAPK signaling pathways. Moreover, the Matrigel invasion assay showed that silibinin reduces PMA-induced invasion of MCF-7 cells. These results suggest that silibinin represents a potential anti-metastatic agent suppressing PMA-induced cancer cell invasion through the specific inhibition of AP-1-dependent MMP-9 gene expression.
Similar articles
-
Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-kappaB-dependent MMP-9 expression.Biochem Biophys Res Commun. 2008 Feb 22;366(4):1019-24. doi: 10.1016/j.bbrc.2007.12.068. Epub 2007 Dec 26. Biochem Biophys Res Commun. 2008. PMID: 18088599
-
Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.Carcinogenesis. 2009 Jul;30(7):1225-33. doi: 10.1093/carcin/bgp111. Epub 2009 May 6. Carcinogenesis. 2009. PMID: 19420016
-
Hyul-Tong-Ryung suppresses PMA-induced MMP-9 expression by inhibiting AP-1-mediated gene expression via ERK 1/2 signaling pathway in MCF-7 human breast cancer cells.Immunopharmacol Immunotoxicol. 2010 Dec;32(4):600-6. doi: 10.3109/08923971003610817. Epub 2010 Feb 4. Immunopharmacol Immunotoxicol. 2010. PMID: 20131957
-
Anticancer potential of silymarin: from bench to bed side.Anticancer Res. 2006 Nov-Dec;26(6B):4457-98. Anticancer Res. 2006. PMID: 17201169 Review.
-
Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy.Cancer Treat Rev. 2015 Jun;41(6):540-6. doi: 10.1016/j.ctrv.2015.04.008. Epub 2015 Apr 27. Cancer Treat Rev. 2015. PMID: 25944486 Review.
Cited by
-
Silibinin Mitigates Vanadium-induced Lung Injury via the TLR4/MAPK/NF-κB Pathway in Mice.In Vivo. 2024 Sep-Oct;38(5):2179-2189. doi: 10.21873/invivo.13681. In Vivo. 2024. PMID: 39187362 Free PMC article.
-
Acacetin, a flavonoid, inhibits the invasion and migration of human prostate cancer DU145 cells via inactivation of the p38 MAPK signaling pathway.Mol Cell Biochem. 2010 Jan;333(1-2):279-91. doi: 10.1007/s11010-009-0229-8. Epub 2009 Aug 20. Mol Cell Biochem. 2010. PMID: 19693651
-
Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy.Curr Cancer Drug Targets. 2013 Jun;13(5):486-99. doi: 10.2174/15680096113139990041. Curr Cancer Drug Targets. 2013. PMID: 23617249 Free PMC article. Review.
-
Suppression of ERK1/2 and hypoxia pathways by four Phyllanthus species inhibits metastasis of human breast cancer cells.J Food Drug Anal. 2016 Oct;24(4):855-865. doi: 10.1016/j.jfda.2016.03.010. Epub 2016 Jun 2. J Food Drug Anal. 2016. PMID: 28911625 Free PMC article.
-
Silybin-Functionalized PCL Electrospun Fibrous Membranes for Potential Pharmaceutical and Biomedical Applications.Polymers (Basel). 2024 Aug 19;16(16):2346. doi: 10.3390/polym16162346. Polymers (Basel). 2024. PMID: 39204566 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous